Studies point to involvement of anti-CCP antibodies and citrullinated targets in the lungs and joints in the development of RA, and suggest an early therapeutic window for prevention
Search results for: hip OA
When Will Generic Biologic Drugs Become Commercially Available?
Biosimilars are challenging to produce, but progress is being made
Rheumatology Circuit Brings Healthcare to Small Towns
Circuit-riding physicians go from hospital to hospital providing specialty services to rheumatology patients in rural areas
President’s Perspective: The ACR and ARHP Advance Rheumatology Through International Collaboration
By forging new connections and strengthening efforts with global organizations such as EULAR, the College hopes to enhance the science, clinical care, and perceived value of rheumatology
Rheuminations: How Tiny Ticks Have Fueled Outrage and Acrimony in Some Communities
A history of rheumatologists’ efforts to diagnose Lyme disease
Speak Out Rheum: Fifty Years of APLAR
A past president reminisces about the formation and history of the Asia Pacific League of Associations for Rheumatology on its 50th anniversary
Arthritis & Rheumatism (A&R) Gets a New Name
Starting in January 2014, the venerable medical journal will be renamed Arthritis & Rheumatology
ACR 2013 State-of-the-Art Clinical Symposium: How to Identify Signs of Myositis and Metabolic Myopathies
Rheumatologists offer tips for diagnosing and treating these diseases
Ethics Forum: Ethics of Infusions in the Face of A Professional Conflict
An infusion prescription ordered by a rheumatologist, but changed by a hematologist, raises dilemmas concerning a patient’s continuity of care
Rheum with a View: How Should We Train Rheumatology Fellows?
Regulatory mandates in the ACGME’s Next Accreditation System aim to improve the way rheumatologists are trained, but they might not have the desired effect
- « Previous Page
- 1
- …
- 265
- 266
- 267
- 268
- 269
- …
- 331
- Next Page »